Tag: hold
Teva Pharmaceutical Stock Analysis: Buy or Sell? Valuation, Growth & Margins
Teva Pharmaceutical Industries Ltd. (TEVA) is rated Hold as the stock has already rerated on an earnings recovery, while revenue still faces generic pricing pressure. The business generates solid cash flow and strong EBITDA margins, but execution on branded growth and the AUSTEDO pricing reset remain key risks.
Target Stock Analysis: Valuation, Free Cash Flow, Margins & Risk
Target (TGT) is rated Hold as the stock already prices in a recovery that still has to prove itself in margins. The company remains profitable and cash generative, but valuation leaves limited room for disappointment if earnings momentum stalls.
Newmont Stock Analysis: Valuation, Free Cash Flow, Margins & Gold
Newmont Corporation (NEM) is rated Hold in this stock analysis. The company generates strong free cash flow and has net cash, but much of the quality appears priced in and upside depends on firm metal prices.